Monday's Analysts' Upgrades and Downgrades
Change in Ratings
8:07 AM EST
Credit Suisse said it is downgrading
ACA Capital
(ACA) - Get Arcosa Inc. Report
to Underperform from Neutral based on future losses in CDO related investments. Lowered target price to $2 from $7.
8:44 AM EST
Amedisys
(AMED) - Get Amedisys Inc Report
was downgraded from Outperform to Market Perform, Wachovia said. Stock has enjoyed a nice run, and 2008 guidance may prove too optimistic.
8:33 AM EST
Cheesecake Factory
(CAKE) - Get The Cheesecake Factory Incorporated Report
was upgraded from Neutral to Buy, Suntrust, Robinson Humphrey said. $26 price target. Stock has pulled back down near the low point of its historical valuation.
7:52 AM EST
Deutsche Bank said it is downgrading Home Depot (HD) - Get Home Depot Inc. (The) Report to a Hold rating as a myriad of data indicates a housing recovery is further off than previously thought.
8:09 AM EST
TheStreet Recommends
K-Swiss
( KSWS) was downgraded to Neutral, Merrill Lynch said. Estimates also cut, as the company continues to ramp investments in its new products.
8:35 AM EST
Legg Mason
(LM) - Get Legg Mason, Inc. Report
was downgraded to Underperform, Wachovia said. Estimates also cut, to reflect lower liquidity and interest income.
7:53 AM EST
Deutsche Bank said it is downgrading
Lowe's
(LOW) - Get Lowe's Companies Inc. Report
to a Hold raing as 2008 estimates look high in light of weak housing market.
7:52 AM EST
Nalco
( NLC) upgraded to Neutral rating from Sell at UBS. Price target and FY 2008 eps estmiates hold at $26 and $1.35, respectively.
8:14 AM EST
Credit Suisse said it is downgrading
Nelnet
(NNI) - Get Nelnet Inc. Report
to Neutral from Outperform. Believes recent legislative changes should result in continued margin compression and slower near-term asset growth. Lowered target price to $20 from $26.
8:26 AM EST
Private Bancorp
(PVTB)
was upgraded to Overweight, JP Morgan said. New management team should help position the company for significant growth.
8:21 AM EST
Vectren
(VVC)
was upgraded from Hold to Buy, Citigroup said. $30.50 price target. Stock should be able to generate steady double-digit returns over the next few years.
7:50 AM EST
West Pharma
(WST) - Get West Pharmaceutical Services Inc. Report
upgraded to Buy rating from Neutral at UBS. Price target and FY 2008 eps estmiates hold at $45 and $2.37, respectively.
Stock Comments/EPS Changes
7:33 AM EST
Goldman said it is cutting its 2007 estimates on
Citigroup
(C) - Get Citigroup Inc. Report
to $2.22 from $3.85 following the announcement of $8 to $11 billion in writedowns on its $55 billion exposure to U.S. sub-prime mortgages/CDOs. Believe market is likely to view management change as positive. Lowered target to $48 from $51 and maintained Neutral rating.
7:58 AM EST
FBR said it is cutting its target price on
FormFactor
(FORM) - Get FormFactor Inc. Report
from $35 to $32 to account for increased risk in light of design loss. Maintained Underperform rating.
7:35 AM EST
Goldman said it is increasing its target on
NYSE Euronext
(NYX)
to $105 from $95 following solid Q3 results. Note volumes continue to benefit from international diversification, especially European derivatives and equities. Maintained Neutral rating.
7:56 AM EST
FBR said it is raising its 2007 estimates on
USEC
(USU)
by 11 cents to 88 cents a share following strong Q3 numbers.
